Kalpana Gupta Shekhawat: Ferritin Is More Than an Iron Marker
Kalpana Gupta Shekhawat, Chairperson at the Functional and Metabolic Medicine Academy, Gurugram, India, shared a post on LinkedIn:
”Ferritin and Methylation: A Link Worth Paying Attention To
Ferritin is usually read as a simple iron storage marker used to rule out anemia. But in clinical practice, it often tells a much wider story – about energy production, brain chemistry, and overall metabolic resilience.
One connection that rarely gets enough attention is ferritin and dopamine. Iron is required for the enzyme tyrosine hydroxylase, which controls the rate of dopamine production.
When iron stores run low, dopamine synthesis can slow down – even when hemoglobin is still normal.
This is why some patients report low drive, poor focus, reduced motivation, sleep changes, or a general sense of ‘slowness,’ despite normal routine labs.
This becomes more relevant in patients with MTHFR variants.
The variant itself is not the issue in isolation – what matters is the biochemical environment around it.
Methylation is a high-demand process that depends on adequate nutrients, especially folate, B12, and iron.
When ferritin is low, the system simply doesn’t have enough reserve to maintain smooth neurotransmitter balance and cellular energy output.
In practice, these patients don’t always look ‘deficient’ on paper.
Hemoglobin may be normal, thyroid values unremarkable, and B-vitamin status adequate – yet symptoms persist. Fatigue, brain fog, hair shedding, and emotional flatness are often what bring them in.
Iron also has a direct role in thyroid physiology. It supports thyroid peroxidase activity and the conversion of T4 to active T3.
Low ferritin can therefore contribute to a hypothyroid-like picture even when TSH is within range, which is often missed in routine screening.
What makes this more complex is that standard reference ranges do not always reflect functional needs.
Ferritin between 15–40 ng/mL is often labeled as ‘normal,’ but many patients remain symptomatic in this range.
The body’s requirement is not uniform – it varies with physiology, stress load, and metabolic demand.
In the end, the real question is not whether ferritin is ‘normal,’ but whether it is enough for that individual’s neurological and metabolic function.
Ferritin sits quietly at the intersection of dopamine, thyroid function, and methylation.
When it is low, the effects are often subtle, but very real – and frequently overlooked in routine clinical interpretation.”

Stay updated with Hemostasis Today.
-
Jul 12, 2026, 16:15Louise St. Germain Bannon: Global Collaboration Is Key to Turning Scientific Innovation Into Better Care
-
Jul 12, 2026, 16:10Marc Carrier: Major Scientific Highlight Confirms the Safety of the YEARS Algorithm at ISTH 2026
-
Jul 12, 2026, 16:01Joseph R. Shaw: Sharing New Insights into Antithrombotic Therapy and Thrombin Generation at ISTH 2026
-
Jul 12, 2026, 15:45Nathan Connell: Key Clinical Advances in Heavy Menstrual Bleeding and Postpartum Hemorrhage from ISTH 2026
-
Jul 12, 2026, 15:40Anne-Claire Duchez: Join Us at ISTH 2026 to Discover Our Latest Research and Meet the Team
-
Jul 12, 2026, 12:30Reduced-Dose DOACs in GI Malignancies: Toward Personalized Anticoagulation
-
Jul 12, 2026, 08:50Where the Hemophilia Community Comes Together at ISTH 2026 – EAHAD
-
Jul 12, 2026, 08:2210 Posts Not To Miss from ISTH 2026, Part 1
-
Jul 12, 2026, 07:58Brian O Mahony: Could NXT-007 Minimize the Need for Perioperative FVIII